Anticancer agent 266

• Description :

  Anticancer agent 266 (Compound 3B) is an anticancer agent that can inhibit the proliferation of tumor cells. Anticancer agent 266 has an IC50 of 0.13 μM for MCF-7 breast cancer cell line[1].

• UNSPSC :

  12352005

• Target :

  Apoptosis

• Related Pathways :

  Apoptosis

• Field of Research :

  Cancer

• Smiles :

  ClC1=CC=CC([N+]([O-])=O)=C1C(C2=CNC3=CC=CC=C32)C4=CNC5=C4C=CC=C5

• Molecular Formula :

  C23H16ClN3O2

• Molecular Weight :

  401.85

• References & Citations :

  [1]Rathi K, et al. Zirconium oxide nano-catalyzed bis (indolyl) methanes: A sustainable route to anticancer therapies. Bioorg Med Chem Lett. 2025 Feb 7;120:130132.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported